galactosyl-(1-3)galactose has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKenzie, IF; Sandrin, MS; Vaughan, HA; Xing, PX | 1 |
| Apostolopoulos, V; McKenzie, IF; Osinski, C | 1 |
2 other study(ies) available for galactosyl-(1-3)galactose and Breast Cancer
| Article | Year |
|---|---|
Natural human anti-Gal alpha(1,3)Gal antibodies react with human mucin peptides.
Topics: Amino Acid Sequence; Animals; Antibodies; Breast; Breast Neoplasms; COS Cells; Cricetinae; Cross Reactions; Disaccharides; Epitopes; Humans; Lectins; Molecular Sequence Data; Mucin-1; Mucin-3; Mucins; Neoplasm Proteins; Peptide Fragments | 1997 |
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral.
Topics: Animals; Antibodies, Neoplasm; Antigen-Presenting Cells; Breast Neoplasms; Cancer Vaccines; Cross Reactions; Disaccharides; Epitopes; Female; Galactosyltransferases; Hematopoietic Stem Cells; Humans; Immunotherapy; Macrophage Activation; Mannans; Mice; Mice, Mutant Strains; Mucin-1; Species Specificity; T-Lymphocytes, Cytotoxic | 1998 |